We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 37 days · 37 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 37 days • 1 price levels
Price Analysis
Most common price: £520 (37 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 37 days
Description
Product Specifications
- Format
- paperback
- ASIN
- B0BLQVZCJW
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in India
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in India
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in the United States
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
The 2023-2028 Outlook for Anticholinergic Motion Sickness Treatments in India
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
The 2023-2028 Outlook for Immune-Oncology Treatments in India
The 2023-2028 Outlook for HPV and CMV Therapeutics in the United States
The 2023-2028 Outlook for Orphan Biologic Drugs in India
The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in the United States
The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in the United States
The 2023-2028 Outlook for Hepatitis Drugs in the United States
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States
The 2023-2028 Outlook for Malignant Melanoma Treatments in India
The 2023-2028 Outlook for Pediatric Health Care Products in India
The 2023-2028 Outlook for Antifungal Drugs in India